Minimal-Incision Technique With Modified Tracking Pin Placement Versus Standard Robotic-Assisted Total Knee Arthroplasty (MISI)

August 10, 2026 updated by: Jung-Il Kim, Hallym University Kangnam Sacred Heart Hospital

Comparison of a Minimal Incision and Minimal Soft-Tissue Injury (MISI) Technique Versus the Standard Technique in Robotic-Assisted Total Knee Arthroplasty: A Randomized Controlled Trial

This randomized controlled trial will compare a minimal-incision and soft-tissue-preserving (MISI) technique with the standard surgical technique in patients undergoing robotic-assisted total knee arthroplasty for knee osteoarthritis. A total of 100 participants will be randomly assigned in a 1:1 ratio to undergo either the MISI technique, which uses a reduced skin incision, limited soft-tissue dissection, and modified tracking pin placement, or the standard technique. The primary outcome is postoperative scar assessment at 3 months. Secondary outcomes include incision length, wound oozing, thigh pain and tenderness, recovery of straight-leg raising, tracking pin-related complications, patellar height, patient-reported scar assessments, and functional outcomes during follow-up.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Robotic-assisted total knee arthroplasty requires surgical exposure and placement of tracking pins. Conventional techniques may involve a relatively long incision, broader soft-tissue dissection, and diaphyseal pin insertion. The MISI technique was developed to reduce surgical invasiveness through a shorter incision, limited soft-tissue dissection, and modified tracking pin placement that avoids diaphyseal pin insertion.

Participants will be randomly assigned to the MISI or standard technique in a 1:1 ratio. Clinical evaluations will be performed during follow-up for up to 12 months. The study will assess whether the MISI technique improves scar-related outcomes and early recovery without increasing procedure-related complications.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Seoul, South Korea
        • Hallym University Kangnam Sacred Heart Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 18 years or older
  • Degenerative knee osteoarthritis requiring robotic-assisted total knee arthroplasty
  • Body mass index below 30 kg/m²
  • Preoperative knee flexion of 90 degrees or greater
  • Ability to understand the study information and provide written informed consent

Exclusion Criteria:

  • Skin lesions or conditions that may adversely affect wound healing
  • Previous intra-articular surgery of the affected knee
  • Inflammatory arthritis, including rheumatoid arthritis
  • Severe hepatic or renal disease associated with poor general health
  • Comorbid conditions that may substantially affect mobility, including Parkinson disease, sequelae of poliomyelitis, or stroke
  • Inability or unwillingness to complete the required follow-up
  • Any medical or other condition that, in the investigator's judgment, makes participation inappropriate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MISI tenchique
Participants will undergo robotic-assisted total knee arthroplasty using the minimal incision and minimal soft-tissue injury (MISI) technique. The procedure uses an approximately 10-cm main incision with limited soft-tissue dissection. Two femoral tracking pins are inserted through the main incision, and one tibial tracking pin is inserted through an additional approximately 5-mm incision.
Robot-assisted total knee arthroplasty performed using an approximately 10-cm main incision, limited soft-tissue dissection, two femoral tracking pins inserted through the main incision, and one tibial tracking pin inserted through an additional approximately 5-mm incision.
Active Comparator: Standard technique
Participants will undergo robotic-assisted total knee arthroplasty using the standard surgical technique. Tracking arrays are secured using the conventional pin placement method, with four tracking pins placed in the femoral and tibial regions and an additional femoral incision.
Robot-assisted total knee arthroplasty performed using the standard incision and soft-tissue exposure, with conventional placement of four tracking pins in the femoral and tibial regions and an additional femoral incision.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient and Observer Scar Assessment Scale Score
Time Frame: 3 months after surgery
The combined Patient and Observer Scar Assessment Scale (POSAS) score is calculated by summing the total Patient Scale score and the total Observer Scale score. Each scale consists of six items rated from 1 to 10, resulting in a score of 6 to 60 for each scale and a combined score ranging from 12 to 120. Higher scores indicate poorer scar quality. The Observer Scale will be completed by an independent outcome assessor blinded to treatment allocation.
3 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient and Observer Scar Assessment Scale Score
Time Frame: 3 and 6 weeks after surgery
The combined Patient and Observer Scar Assessment Scale (POSAS) score is calculated by summing the total Patient Scale score and the total Observer Scale score. Each scale consists of six items rated from 1 to 10, resulting in a score of 6 to 60 for each scale and a combined score ranging from 12 to 120. Higher scores indicate poorer scar quality. The Observer Scale will be completed by an independent outcome assessor blinded to treatment allocation.
3 and 6 weeks after surgery
Main Surgical Incision Length
Time Frame: During surgery and on postoperative day 1
The length of the main surgical incision will be measured in centimeters. The initial incision length will be measured immediately after the skin incision with the knee in extension, and the final incision length will be measured before wound closure. The incision length will also be evaluated on postoperative day 1. Separate tracking pin-site incisions will not be included.
During surgery and on postoperative day 1
Intraoperative Incision Stretching Index
Time Frame: During surgery
The incision stretching index is calculated as the maximum length of the main incision during knee flexion and maximal surgical retraction divided by the initial incision length measured with the knee in extension. A value of 1 indicates no stretching, and higher values indicate greater intraoperative stretching of the incision and surrounding soft tissue.
During surgery
Postoperative Gauze Oozing Grade
Time Frame: Postoperative days 1, 2, 4, and 6
Postoperative wound oozing will be assessed according to the amount of blood or exudate visible on the surgical dressing using a prespecified ordinal grading scale. Higher grades indicate more extensive wound oozing.
Postoperative days 1, 2, 4, and 6
Thigh Pain at Rest on the Numeric Rating Scale
Time Frame: Postoperative days 1, 2, 4, and 6
Participants will rate thigh pain at rest using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Postoperative days 1, 2, 4, and 6
Thigh Pain During Active Hip Flexion on the Numeric Rating Scale
Time Frame: Postoperative days 1, 2, 4, and 6
Participants will rate thigh pain during active hip flexion while maintaining knee extension and without external resistance. Pain will be assessed using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Postoperative days 1, 2, 4, and 6
Tenderness at the Standardized Tracking Pin-Site Location
Time Frame: Postoperative days 1, 2, 4, and 6
Tenderness elicited by palpation at a prespecified standardized anatomical location corresponding to the tracking pin region will be rated using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no tenderness and 10 indicates the worst imaginable tenderness.
Postoperative days 1, 2, 4, and 6
Ability to Perform Straight-Leg Raising
Time Frame: Postoperative days 1, 2, 4, and 6
The participant's ability to independently raise the operated lower extremity while maintaining knee extension will be recorded as a binary outcome: able or unable to perform straight-leg raising. The number and proportion of participants able to perform the test will be compared between groups.
Postoperative days 1, 2, 4, and 6
Pain During the Resisted Straight-Leg-Raising Test
Time Frame: Postoperative days 1, 2, 4, and 6
Pain during resisted straight-leg raising will be assessed using a 100-mm visual analog scale, where 0 mm indicates no pain and 100 mm indicates the worst imaginable pain.
Postoperative days 1, 2, 4, and 6
Incidence of Tracking Pin-Site Complications
Time Frame: Postoperative days 1, 2, 4, and 6 and postoperative week 3
Tracking pin sites will be examined for complications, including erythema, swelling, wound drainage, infection, and pin-related fracture. The occurrence of one or more prespecified pin-site complications will be recorded as a binary outcome, and the number and proportion of participants with any complication will be reported.
Postoperative days 1, 2, 4, and 6 and postoperative week 3
Forgotten Joint Score-12
Time Frame: 6 and 12 months after surgery
The Forgotten Joint Score-12 is a 12-item patient-reported questionnaire assessing awareness of the operated knee during daily activities. Scores are transformed to a scale ranging from 0 to 100, with higher scores indicating less awareness of the artificial joint and a better outcome.
6 and 12 months after surgery
Western Ontario and McMaster Universities Osteoarthritis Index
Time Frame: 6 and 12 months after surgery
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) assesses knee pain, stiffness, and physical function. The 24 items are scored using a 5-point Likert scale, producing a total score ranging from 0 to 96. Higher scores indicate more severe symptoms and poorer physical function.
6 and 12 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Joong-Il Kim, MD, PhD, Hallym University Kangnam Sacred Heart Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 17, 2026

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

May 31, 2028

Study Registration Dates

First Submitted

August 10, 2026

First Submitted That Met QC Criteria

August 10, 2026

First Posted (Actual)

August 14, 2026

Study Record Updates

Last Update Posted (Actual)

August 14, 2026

Last Update Submitted That Met QC Criteria

August 10, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • HKS 2026-05-024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.